Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy-Reference-Cited by-同舟云学术

Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy

Published:2021-12 Issue:12 Volume:32 Page:1637-1642
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Remon J.,Soria J.-C.,Peters S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference15 articles.

1. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Postmus;Ann Oncol,2017

2. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer;De Leyn;Eur J Cardiothorac Surg,2014

3. Osimertinib in resected EGFR-mutated non-small-cell lung cancer;Wu;N Engl J Med,2020

4. Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA;Herbst;J Clin Oncol,2020

5. IMpower010 Investigators. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial;Felip;Lancet,2021

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of adjuvant therapy for cisplatin-unfit patients with non-small-cell lung cancer: A multicenter analysis;Lung Cancer;2024-02

2. Co-encapsulation of fisetin and cisplatin into liposomes: Stability considerations and in vivo efficacy on lung cancer animal model;International Journal of Pharmaceutics;2024-02

3. Single isocenter versus dual isocenter treatment using flattening filter‐free and jaw‐tracking volumetrically modulated arc therapy for boot‐shaped lung cancer: Evaluation of dosimetric and feasibility;Journal of Applied Clinical Medical Physics;2024-01-29

4. DHX38 enhances proliferation, metastasis, and EMT progression in NSCLC through the G3BP1-mediated MAPK pathway;Cellular Signalling;2024-01

5. Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study;Respiratory Medicine and Research;2024-01